Physician profile
Roy M Fujitani
NPI 1164429015
$57,150.88
in general payments reported to CMS, 2019-2025
20 companies · $21K in 2025
The $21K reported for 2025 was more than what 95% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $4,500 · 2021: $2,401 · 2022: $2,783 · 2023: $2,694 · 2024: $14K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Travel and Lodging: $9,750 · Food and Beverage: $4,789 · Consulting Fee: $875 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,600.00 |
| Travel and Lodging | $9,749.78 |
| Food and Beverage | $4,788.99 |
| Consulting Fee | $875.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $38,149.97 | 2021-2025 | Endurant Iis, Valiant Captivia, Abre |
| Medtronic Vascular, INC. | $10,465.75 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $3,239.72 | 2019-2024 | Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm |
| W. L. Gore & Associates, INC. | $1,469.15 | 2023-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Terumo Medical Corporation | $1,086.98 | 2019 | |
| Provisio Medical, INC. | $500.00 | 2023 | |
| Inari Medical, INC. | $468.92 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merit Medical Systems INC | $465.23 | 2024-2025 | Hero Graft, Surfacer Inside-Out Catheter |
| Silk Road Medical, INC. | $289.64 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Artivion, INC. | $209.76 | 2022 | |
| Cagent Vascular INC | $201.36 | 2023 | Serrantor |
| Penumbra, INC. | $146.50 | 2024 | Indigo System |
| Ethicon US, LLC | $144.07 | 2025 | Ethicon, Vistaseal |
| Philips North America LLC | $114.22 | 2023 | |
| Bolton Medical INC | $62.53 | 2025 | Treo Abdominal Stent-Graft System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ziehm-Orthoscan, INC. | $46.29 | 2022 | |
| Cvrx, INC. | $39.41 | 2025 | Barostim Neo System |
| Lemaitre Vascular, INC. | $27.98 | 2021-2024 | Artegraft Vascular Graft |
| Mindray Ds USA, INC. | $23.40 | 2025 | Te7 Max, Te X |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Fujitani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.